{
    "clinical_study": {
        "@rank": "53751", 
        "arm_group": [
            {
                "arm_group_label": "Metformin and Metformin & L-Citrulline", 
                "arm_group_type": "Experimental", 
                "description": "1500 mg/d metformin for 6 weeks, followed by 1500 mg/d metformin and 15 g/d L-citrulline for 6 further weeks"
            }, 
            {
                "arm_group_label": "L-Citrulline and Metformin & L-Citrulline", 
                "arm_group_type": "Experimental", 
                "description": "15 g/d L-citrulline for 6 weeks, followed by 1500 mg/d metformin and 15 g/d L-citrulline for 6 further weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to compare the effects of L-citrulline and metformin and their\n      combination therapy on muscle function and force in patients with Becker muscular dystrophy\n      (BMD)."
        }, 
        "brief_title": "L-citrulline and Metformin in Becker's Muscular Dystrophy", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Becker's Muscular Dystrophy (BMD)", 
        "condition_browse": {
            "mesh_term": [
                "Muscular Dystrophy, Duchenne", 
                "Muscular Dystrophies"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a single center, not-randomized open study. The study medication consists of\n      L-citrulline and metformin administered orally; 5g citrulline and 500mg metformin tablets\n      will be given 3 times daily.\n\n      Half of the patients will be treated with metformin during the first 6 weeks of the study.\n      The other patients will receive initially L-citrulline for 6 weeks, before all patients will\n      be treated with the combination therapy (metformin and L-citrulline) for another 6 week\n      period.\n\n      The study lasts 12 weeks and includes the screening visit and 3 further visits at baseline,\n      week 6 and week 12."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 years or older\n\n          -  Molecular or immunohistochemical diagnosis of BMD\n\n          -  ambulant at the time point of screening\n\n        Exclusion Criteria:\n\n          -  Participation in another therapeutic BMD study within the last 3 months\n\n          -  Use of L-Arginine, L-Citrulline or Metformin within the last 3 months\n\n          -  Other chronic disease or relevant limitation of renal, liver, heart function\n             according to discretion of investigator\n\n          -  known hypersensitivity to L-citrulline or metformin"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02018731", 
            "org_study_id": "BMD01"
        }, 
        "intervention": [
            {
                "arm_group_label": "Metformin and Metformin & L-Citrulline", 
                "intervention_name": "Metformin and Metformin & L-Citrulline", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "L-Citrulline and Metformin & L-Citrulline", 
                "intervention_name": "L-Citrulline and Metformin & L-Citrulline", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Metformin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Becker's Muscular dystrophy", 
            "BMD", 
            "Metformin", 
            "L-citrulline"
        ], 
        "lastchanged_date": "December 17, 2013", 
        "location": {
            "contact": {
                "email": "ulrike.bonati@ukbb.ch", 
                "last_name": "Ulrike Bonati, MD", 
                "phone": "+41617042243"
            }, 
            "contact_backup": {
                "email": "daniela.rubino@ukbb.ch", 
                "last_name": "Daniela Rubino"
            }, 
            "facility": {
                "address": {
                    "city": "Basel", 
                    "country": "Switzerland", 
                    "state": "BS", 
                    "zip": "4031"
                }, 
                "name": "University Children's Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "2", 
        "official_title": "Pilot Study to Assess the Efficacy of L-Citrulline and Metformin in Adults With Becker's Muscular Dystrophy", 
        "overall_contact": {
            "email": "ulrike.bonati@ukbb.ch", 
            "last_name": "Ulrike Bonati, MD", 
            "phone": "+41617042243"
        }, 
        "overall_contact_backup": {
            "email": "daniela.rubino@ukbb.ch", 
            "last_name": "Daniela Rubino"
        }, 
        "overall_official": {
            "affiliation": "University Children's Hospital Basel", 
            "last_name": "Dirk Fischer, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Swissmedic", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Mean change of motor function measure (MFM) D1 subscore after 6 and 12 weeks", 
            "safety_issue": "No", 
            "time_frame": "week 6 and week 12"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02018731"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "MFM total score and six minute walking distance (6MWD)", 
                "safety_issue": "No", 
                "time_frame": "week 6 and week 12"
            }, 
            {
                "measure": "Change of muscle fat content (MFC) (assessed by MRI)", 
                "safety_issue": "No", 
                "time_frame": "week 6 and week 12"
            }, 
            {
                "measure": "Change of muscle metabolism (assessed by dual energy x-ray absorptiometry  (DEXA) and indirect calorimetry)", 
                "safety_issue": "No", 
                "time_frame": "week 6 and week 12"
            }, 
            {
                "measure": "Change of laboratory parameters (oxidative and nitrosative stress)", 
                "safety_issue": "No", 
                "time_frame": "week 6 and week 12"
            }
        ], 
        "source": "University Hospital, Basel, Switzerland", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Basel, Switzerland", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}